🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Primary T-cell Immunodeficiency Disorders

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites📍 Duarte📍 Chicago📍 New York AIDS Malignancy Consortium · Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) NCT04197596Phase 1, Phase 27 sites📍 San Francisco📍 Baltimore📍 St Louis New York Medical College · Tests: BK CTL Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death NCT00246857n/a8 sites📍 Bethesda📍 Ann Arbor📍 Ankara National Institute of Allergy and Infectious Diseases (NIAI… Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity NCT04339777Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Busulfan test dose, Fludarabine, Busulfan, Alemtuzumab, Total body Irradiation Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) NCT01306019Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL… Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) NCT03266640Phase 29 sites📍 Los Angeles📍 San Francisco📍 Indianapolis New York Medical College · Tests: viral specific cytotoxic t-lymphocytes Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT NCT06839456Phase 1, Phase 21 site📍 Philadelphia Children's Hospital of Philadelphia · Tests: Phase 1 Dose Level 1, Phase 1 Dose Level 2, Phase 1 Dose Level 3, Phase 2 Maximum Tolerated Dose determined in Phase 1,… Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies NCT02579967Phase 22 sites📍 Bethesda📍 Minneapolis National Cancer Institute (NCI) · Tests: Immunosuppression Only Conditioning -Closed with amendment L, Reduced Intensity Conditioning, Myeloablative Conditionin… Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts NCT04691622Phase 13 sites📍 Washington D.C.📍 Baltimore📍 Bethesda Children's National Research Institute · Tests: Norovirus -specific T-cell (NST) therapy The Mechanistic Biology of Primary Immunodeficiency Disorders NCT03394053n/a2 sites📍 Washington D.C.📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children NCT04414046Phase 21 site📍 St. Petersburg Johns Hopkins All Children's Hospital · Tests: Haploidentical Hematopoietic Cell Transplantation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy